Dainippon Sumitomo To Put Muscles Behind Lurasidone
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma President Masayo Tada said the company aims to bring in ¥70 billion in sales for its antipsychotic drug Latuda (lurasione) in 2014